Literature DB >> 26004086

TIPIN depletion leads to apoptosis in breast cancer cells.

Céline Baldeyron1, Amélie Brisson1, Bruno Tesson2, Fariba Némati3, Stéphane Koundrioukoff4, Elie Saliba1, Leanne De Koning5, Elise Martel6, Mengliang Ye1, Guillem Rigaill7, Didier Meseure6, André Nicolas6, David Gentien8, Didier Decaudin3, Michelle Debatisse4, Stéphane Depil9, Francisco Cruzalegui9, Alain Pierré9, Sergio Roman-Roman1, Gordon C Tucker9, Thierry Dubois10.   

Abstract

Triple-negative breast cancer (TNBC) is the breast cancer subgroup with the most aggressive clinical behavior. Alternatives to conventional chemotherapy are required to improve the survival of TNBC patients. Gene-expression analyses for different breast cancer subtypes revealed significant overexpression of the Timeless-interacting protein (TIPIN), which is involved in the stability of DNA replication forks, in the highly proliferative associated TNBC samples. Immunohistochemistry analysis showed higher expression of TIPIN in the most proliferative and aggressive breast cancer subtypes including TNBC, and no TIPIN expression in healthy breast tissues. The depletion of TIPIN by RNA interference impairs the proliferation of both human breast cancer and non-tumorigenic cell lines. However, this effect may be specifically associated with apoptosis in breast cancer cells. TIPIN silencing results in higher levels of single-stranded DNA (ssDNA), indicative of replicative stress (RS), in TNBC compared to non-tumorigenic cells. Upon TIPIN depletion, the speed of DNA replication fork was significantly decreased in all BC cells. However, TIPIN-depleted TNBC cells are unable to fire additional replication origins in response to RS and therefore undergo apoptosis. TIPIN knockdown in TNBC cells decreases tumorigenicity in vitro and delays tumor growth in vivo. Our findings suggest that TIPIN is important for the maintenance of DNA replication and represents a potential treatment target for the worst prognosis associated breast cancers, such as TNBC.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Basal-like; Replicative stress; TIPIN; Therapeutic target; Triple-negative breast cancer

Mesh:

Substances:

Year:  2015        PMID: 26004086      PMCID: PMC5528799          DOI: 10.1016/j.molonc.2015.04.010

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  69 in total

1.  The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.

Authors:  Paraic A Kenny; Genee Y Lee; Connie A Myers; Richard M Neve; Jeremy R Semeiks; Paul T Spellman; Katrin Lorenz; Eva H Lee; Mary Helen Barcellos-Hoff; Ole W Petersen; Joe W Gray; Mina J Bissell
Journal:  Mol Oncol       Date:  2007-06       Impact factor: 6.603

2.  Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.

Authors:  Cynthia X Ma; Shirong Cai; Shunqiang Li; Christine E Ryan; Zhanfang Guo; W Timothy Schaiff; Li Lin; Jeremy Hoog; Reece J Goiffon; Aleix Prat; Rebecca L Aft; Matthew J Ellis; Helen Piwnica-Worms
Journal:  J Clin Invest       Date:  2012-03-26       Impact factor: 14.808

3.  Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress.

Authors:  Michael G Kemp; Zafer Akan; Seçil Yilmaz; Mary Grillo; Stephanie L Smith-Roe; Tae-Hong Kang; Marila Cordeiro-Stone; William K Kaufmann; Robert T Abraham; Aziz Sancar; Keziban Unsal-Kaçmaz
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  Human Tim/Timeless-interacting protein, Tipin, is required for efficient progression of S phase and DNA replication checkpoint.

Authors:  Naoko Yoshizawa-Sugata; Hisao Masai
Journal:  J Biol Chem       Date:  2006-11-13       Impact factor: 5.157

5.  Timeless functions independently of the Tim-Tipin complex to promote sister chromatid cohesion in normal human fibroblasts.

Authors:  Stephanie L Smith-Roe; Shivani S Patel; Dennis A Simpson; Ying Chun Zhou; Shangbang Rao; Joseph G Ibrahim; Kathleen A Kaiser-Rogers; Marila Cordeiro-Stone; William K Kaufmann
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

6.  The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement.

Authors:  Keziban Unsal-Kaçmaz; Paul D Chastain; Ping-Ping Qu; Parviz Minoo; Marila Cordeiro-Stone; Aziz Sancar; William K Kaufmann
Journal:  Mol Cell Biol       Date:  2007-02-12       Impact factor: 4.272

7.  Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion.

Authors:  Adam R Leman; Chiaki Noguchi; Candice Y Lee; Eishi Noguchi
Journal:  J Cell Sci       Date:  2010-02-02       Impact factor: 5.285

8.  Dormant origins licensed by excess Mcm2-7 are required for human cells to survive replicative stress.

Authors:  Xin Quan Ge; Dean A Jackson; J Julian Blow
Journal:  Genes Dev       Date:  2007-12-15       Impact factor: 11.361

9.  TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival.

Authors:  Kenya Yoshida; Mitsuo Sato; Tetsunari Hase; Momen Elshazley; Ryo Yamashita; Noriyasu Usami; Tetsuo Taniguchi; Kohei Yokoi; Shigeo Nakamura; Masashi Kondo; Luc Girard; John D Minna; Yoshinori Hasegawa
Journal:  Cancer Sci       Date:  2013-01-07       Impact factor: 6.716

Review 10.  Replication stress and cancer: it takes two to tango.

Authors:  Emilio Lecona; Oscar Fernández-Capetillo
Journal:  Exp Cell Res       Date:  2014-09-26       Impact factor: 3.905

View more
  14 in total

1.  TIPIN depletion leads to apoptosis in breast cancer cells.

Authors:  Céline Baldeyron; Amélie Brisson; Bruno Tesson; Fariba Némati; Stéphane Koundrioukoff; Elie Saliba; Leanne De Koning; Elise Martel; Mengliang Ye; Guillem Rigaill; Didier Meseure; André Nicolas; David Gentien; Didier Decaudin; Michelle Debatisse; Stéphane Depil; Francisco Cruzalegui; Alain Pierré; Sergio Roman-Roman; Gordon C Tucker; Thierry Dubois
Journal:  Mol Oncol       Date:  2015-05-09       Impact factor: 6.603

2.  Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer.

Authors:  Hamza Mameri; Ivan Bièche; Didier Meseure; Elisabetta Marangoni; Géraldine Buhagiar-Labarchède; André Nicolas; Sophie Vacher; Rosine Onclercq-Delic; Vinodh Rajapakse; Sudhir Varma; William C Reinhold; Yves Pommier; Mounira Amor-Guéret
Journal:  Clin Cancer Res       Date:  2016-09-06       Impact factor: 12.531

3.  LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers.

Authors:  Sylvie Maubant; Tania Tahtouh; Amélie Brisson; Virginie Maire; Fariba Némati; Bruno Tesson; Mengliang Ye; Guillem Rigaill; Maïté Noizet; Aurélie Dumont; David Gentien; Bérengère Marty-Prouvost; Leanne de Koning; Sardar Faisal Mahmood; Didier Decaudin; Francisco Cruzalegui; Gordon C Tucker; Sergio Roman-Roman; Thierry Dubois
Journal:  Oncotarget       Date:  2018-04-27

Review 4.  At the Beginning of the End and in the Middle of the Beginning: Structure and Maintenance of Telomeric DNA Repeats and Interstitial Telomeric Sequences.

Authors:  Anna Y Aksenova; Sergei M Mirkin
Journal:  Genes (Basel)       Date:  2019-02-05       Impact factor: 4.096

5.  LRP8 is overexpressed in estrogen-negative breast cancers and a potential target for these tumors.

Authors:  Virginie Maire; Faisal Mahmood; Guillem Rigaill; Mengliang Ye; Amélie Brisson; Fariba Némati; David Gentien; Gordon C Tucker; Sergio Roman-Roman; Thierry Dubois
Journal:  Cancer Med       Date:  2018-12-21       Impact factor: 4.452

6.  Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers.

Authors:  Mathilde Vinet; Samyuktha Suresh; Virginie Maire; Clarisse Monchecourt; Fariba Némati; Laetitia Lesage; Fabienne Pierre; Mengliang Ye; Auriane Lescure; Amélie Brisson; Didier Meseure; André Nicolas; Guillem Rigaill; Elisabetta Marangoni; Elaine Del Nery; Sergio Roman-Roman; Thierry Dubois
Journal:  Cancer Med       Date:  2019-04-08       Impact factor: 4.452

7.  Predicting chemosensitivity using drug perturbed gene dynamics.

Authors:  Joshua D Mannheimer; Ashok Prasad; Daniel L Gustafson
Journal:  BMC Bioinformatics       Date:  2021-01-07       Impact factor: 3.169

8.  Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis.

Authors:  Jiamei Liu; Shengye Liu; Xianghong Yang
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

9.  A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

Authors:  Sander Canisius; Marjanka K Schmidt; Maria Escala-Garcia; Jean Abraham; Irene L Andrulis; Hoda Anton-Culver; Volker Arndt; Alan Ashworth; Paul L Auer; Päivi Auvinen; Matthias W Beckmann; Jonathan Beesley; Sabine Behrens; Javier Benitez; Marina Bermisheva; Carl Blomqvist; William Blot; Natalia V Bogdanova; Stig E Bojesen; Manjeet K Bolla; Anne-Lise Børresen-Dale; Hiltrud Brauch; Hermann Brenner; Sara Y Brucker; Barbara Burwinkel; Carlos Caldas; Federico Canzian; Jenny Chang-Claude; Stephen J Chanock; Suet-Feung Chin; Christine L Clarke; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Mary B Daly; Joe Dennis; Peter Devilee; Janet A Dunn; Alison M Dunning; Miriam Dwek; Helena M Earl; Diana M Eccles; A Heather Eliassen; Carolina Ellberg; D Gareth Evans; Peter A Fasching; Jonine Figueroa; Henrik Flyger; Manuela Gago-Dominguez; Susan M Gapstur; Montserrat García-Closas; José A García-Sáenz; Mia M Gaudet; Angela George; Graham G Giles; David E Goldgar; Anna González-Neira; Mervi Grip; Pascal Guénel; Qi Guo; Christopher A Haiman; Niclas Håkansson; Ute Hamann; Patricia A Harrington; Louise Hiller; Maartje J Hooning; John L Hopper; Anthony Howell; Chiun-Sheng Huang; Guanmengqian Huang; David J Hunter; Anna Jakubowska; Esther M John; Rudolf Kaaks; Pooja Middha Kapoor; Renske Keeman; Cari M Kitahara; Linetta B Koppert; Peter Kraft; Vessela N Kristensen; Diether Lambrechts; Loic Le Marchand; Flavio Lejbkowicz; Annika Lindblom; Jan Lubiński; Arto Mannermaa; Mehdi Manoochehri; Siranoush Manoukian; Sara Margolin; Maria Elena Martinez; Tabea Maurer; Dimitrios Mavroudis; Alfons Meindl; Roger L Milne; Anna Marie Mulligan; Susan L Neuhausen; Heli Nevanlinna; William G Newman; Andrew F Olshan; Janet E Olson; Håkan Olsson; Nick Orr; Paolo Peterlongo; Christos Petridis; Ross L Prentice; Nadege Presneau; Kevin Punie; Dhanya Ramachandran; Gad Rennert; Atocha Romero; Mythily Sachchithananthan; Emmanouil Saloustros; Elinor J Sawyer; Rita K Schmutzler; Lukas Schwentner; Christopher Scott; Jacques Simard; Christof Sohn; Melissa C Southey; Anthony J Swerdlow; Rulla M Tamimi; William J Tapper; Manuel R Teixeira; Mary Beth Terry; Heather Thorne; Rob A E M Tollenaar; Ian Tomlinson; Melissa A Troester; Thérèse Truong; Clare Turnbull; Celine M Vachon; Lizet E van der Kolk; Qin Wang; Robert Winqvist; Alicja Wolk; Xiaohong R Yang; Argyrios Ziogas; Paul D P Pharoah; Per Hall; Lodewyk F A Wessels; Georgia Chenevix-Trench; Gary D Bader; Thilo Dörk; Douglas F Easton
Journal:  Nat Commun       Date:  2020-01-16       Impact factor: 14.919

10.  AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells.

Authors:  Olivier Zajac; Renaud Leclere; André Nicolas; Didier Meseure; Caterina Marchiò; Anne Vincent-Salomon; Sergio Roman-Roman; Marie Schoumacher; Thierry Dubois
Journal:  Cells       Date:  2020-01-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.